Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00062101 | Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00040794 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00006929 | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | 82 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00055757 | Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00118183 | Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer(PENGUIN) | completed | Phase 2 | 41 | Genentech, Inc.INDUSTRY | 2 | May 21, 2013 | clinicaltrials |
| NCT00716534 | Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 145 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Apr 29, 2013 | clinicaltrials |
| NCT00517790 | Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 140 | AbbVie (prior sponsor, Abbott)INDUSTRY | 5 | Apr 5, 2013 | clinicaltrials |
| NCT00865319 | Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | Cell>Point LLCINDUSTRY | 2 | Mar 22, 2013 | clinicaltrials |
| NCT00951613 | A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | 72 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00028028 | CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00029003 | Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00075751 | Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 99 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00087412 | S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00777309 | A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 167 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 6 | Feb 28, 2013 | clinicaltrials |
| NCT00021060 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 842 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00077350 | A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00824746 | Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)(ReGaiN) | completed | Phase 2 | 23 | Chonnam National University HospitalOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | completed | Phase 2 | 247 | Eli Lilly and CompanyINDUSTRY | 7 | Feb 13, 2013 | clinicaltrials |
| NCT00265317 | A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone(SUN1058) | completed | Phase 2 | 162 | PfizerINDUSTRY | 8 | Feb 6, 2013 | clinicaltrials |
| NCT00280787 | Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim | completed | Phase 2 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00297089 | A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 165 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Jan 31, 2013 | clinicaltrials |
| NCT00391248 | Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) | completed | Phase 2 | 40 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT01196234 | Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer(PRIDE) | completed | Phase 2 | 84 | Asan Medical CenterOTHER | 1 | Jan 29, 2013 | clinicaltrials |
| NCT00074022 | GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT01770795 | A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer | completed | Phase 2 | 45 | Gachon University Gil Medical CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00387374 | Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab | completed | Phase 2 | 72 | National Cancer Institute (NCI)NIH | 0 | Jan 17, 2013 | clinicaltrials |
| NCT00004883 | Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 | completed | Phase 2 | 84 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00050674 | Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma | completed | Phase 2 | 40 | Schwartzberg, Lee, M.D.INDIV | 1 | Dec 27, 2012 | clinicaltrials |
| NCT00379665 | Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy | completed | Phase 2 | 25 | Southwestern Regional Medical CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00294190 | Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer | completed | Phase 2 | 38 | SCRI Development Innovations, LLCOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00891579 | Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 161 | Chinese Society of Lung CancerOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 26 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00840125 | Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment | completed | Phase 2 | 4 | Meir Medical CenterOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01687439 | Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 109 | Daiichi SankyoINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | completed | Phase 2 | 103 | OSI PharmaceuticalsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | completed | Phase 2 | 143 | OSI PharmaceuticalsINDUSTRY | 2 | Aug 9, 2012 | clinicaltrials |
| NCT00680940 | A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 221 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors(DIPROCOL) | completed | Phase 2 | 30 | Centre Oscar LambretOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00065429 | Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | ImmunoGen, Inc.INDUSTRY | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00401492 | MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 159 | National Cancer Institute, NaplesOTHER | 0 | Jul 13, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 19, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 6, 2013source: clinicaltrials